Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 10, 2015 (12 years ago)

Biest Td 50/50

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Cause type: Cross-contamination

Traces of another drug - most often penicillin - got into the product from shared equipment or facilities. Even trace penicillin can trigger a severe allergic reaction in someone who was never meant to receive it. All cross-contamination recalls.

What was recalled

BIEST TD 50/50 (Estradiol USP Micronized (E2)/Estriol USP Micronized (E3)) W/V (weight /volume) 4.0 MG/ML transdermal cream packaged in 3mL syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.

Drug: Estradiol

Recalling firm
the Compounder
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0188-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Estradiol recalls

See all
Class II · Moderate risk

Alyacen 7/7/7

Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

Ongoing Impurity / degradation Glenmark Pharmaceuticals Inc., USA NDC 68462-556-29 D-0588-2026
Class II · Moderate risk

Estradiol Gel

Defective Container; packets were found to be either empty or partially full.

Ongoing Packaging defect ANI Pharmaceuticals, Inc. NDC 70954-531-20 D-0543-2026
Class II · Moderate risk

Estradiol

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0315-2026
Class II · Moderate risk

Estradiol

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0314-2026
Class II · Moderate risk

Estradiol

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0313-2026

Other recalls by the Compounder

All 2015 recalls
Class II · Moderate risk

Triest 80/10/10

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0228-2016
Class II · Moderate risk

Triest 80/10/10

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0227-2016
Class II · Moderate risk

Triest 70/20/10

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0226-2016
Class II · Moderate risk

Estriol 5 Estradiol

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0225-2016